Maetzold Derek J's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Mar 28, 2025
- Accession no.
- 0001447362-25-000049
- Filed
- Mar 28, 2025
- Trade date
- Mar 26, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions. Open-market sales total $114.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maetzold Derek JCIK 0001239501 | Director, Officer (Pres. & Chief Exec. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 26, 2025 | Common Stock | SSaleDisposed | −1,236 | $20.30F2 | −$25,090.8 | 77,099 | Direct | |
| Mar 26, 2025 | Common Stock | SSaleDisposed | −2,017 | $20.30F2 | −$40,945.1 | 65,025 | Indirect | |
| Mar 26, 2025 | Common Stock | SSaleDisposed | −1,731 | $20.30F2 | −$35,139.3 | 55,372 | Indirect | |
| Mar 26, 2025 | Common Stock | SSaleDisposed | −165 | $20.30F2 | −$3,349.5 | 4,608 | Indirect | |
| Mar 26, 2025 | Common Stock | SSaleDisposed | −165 | $20.30F2 | −$3,349.5 | 4,605 | Indirect | |
| Mar 26, 2025 | Common Stock | SSaleDisposed | −165 | $20.30F2 | −$3,349.5 | 4,605 | Indirect | |
| Mar 26, 2025 | Common Stock | SSaleDisposed | −165 | $20.30F2 | −$3,349.5 | 4,605 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $20.01 to $20.72, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.